Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 7, 2010
- Accepted March 21, 2011
- Published online May 17, 2011.
Article Versions
- Earlier version (March 22, 2011 - 08:03).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jie Wei,
- Jeffrey Jones,
- Jing Kang,
- Ananda Card,
- Michael Krimm,
- Paula Hancock,
- Yi Pei,
- Brandon Ason,
- Elmer Payson,
- Natalya Dubinina,
- Mark Cancilla,
- Mark Stroh,
- Julja Burchard,
- Alan B. Sachs,
- Jerome H. Hochman,
- W. Michael Flanagan and
- Nelly A. Kuklin
- Sirna Therapeutics, a wholly owned subsidiary of Merck & Co, Inc., San Francisco, California (J.W., J.J., J.K., A.C., M.K., B.A., E.P., N.D., M.C., J.B., A.B.S., W.M.F., N.A.K.); and RNA Delivery (P.H., Y.P.) and Clinical PK/PD, Merck Research Laboratories, West Point, Pennsylvania (M.S., J.H.H.)
- Address correspondence to:
Nelly A. Kuklin, Sirna Therapeutics, a wholly owned subsidiary of Merck and Co Inc., 1700 Owens St., 4th Floor, San Francisco, CA 94158. E-mail: nelly_kuklin{at}merck.com